fbpx Invitation to the Annual Biomedical Distinguished Lecture Series | Chestnut Hill College Skip to content Skip to navigation
Menu

Invitation to the Annual Biomedical Distinguished Lecture Series

Invitation to the Annual Biomedical Distinguished Lecture Series

April 10, 2019 - 2:30pm
Location: 
Chestnut Hill College

We hope your senior year is going well! We wanted to invite you to our Annual Biomedical Distinguished Lecture Series Featuring Dr. Jonathon Brody, PH.D. on Wednesday April 10th at 2:00 PM, you can register here.

As a potential STEM student, we thought Dr. Brody’s Lecture was the perfect way for you to see what type of opportunities to expect as a student at Chestnut Hill College. If you have any questions about the lecture or Chestnut Hill please let us know.

Jonathan Brody is currently the Director of Surgical Research and Co-director of the Jefferson Pancreatic, Billary, and Related Cancer Center. He is also a member of the Kimmel Cancer Center (with a leadership role in GI Program) and a professor within the departments of Surgery and Pathology. Dr. Brody received his Ph.D. from The Johns Hopkins University School of Medicine and his thesis specialized in studying the molecular aspects of cancer and cancer genetics. He patented, with Dr. Scott Kern, novel buffers for DNA identification that have changed the format of this molecular biology technique used to detect DNA. He was elected Chair of the Cancer Research Program, Department of Defense Council and serves on many international study sections including currently being the Chair of the Tumor Biology and Genomics study section for the American Cancer Society and NCI study section panels. He has published over 100 peer review publications in many top tier scientific and cancer journals. Additionally, he was an American Cancer Society Research Scholar, is NIH funded, and won the American Association of Cancer Research, Pancreatic Cancer Career Development Award in 2010. His lab focuses on the many molecular aspects of pancreatic cancer, including developing ways to target a novel pro-survival network in pancreatic cancer cells and optimizing current therapies used in the clinic. He also has an interest in personalizing therapy for pancreatic cancer patients.

Thanks, and we hope to see you at the lecture!

Open/Applies to: 
Public
Prospective Students